Literature DB >> 35235178

Protective and pathogenic role of humoral responses in COVID-19.

Uni Park1,2, Nam-Hyuk Cho3,4,5,6,7.   

Abstract

Since the advent of SARS-CoV-2 in Dec. 2019, the global endeavor to identify the pathogenic mechanism of COVID-19 has been ongoing. Although humoral immunity including neutralizing activity play an important role in protection from the viral pathogen, dysregulated antibody responses may be associated with the pathogenic progression of COVID-19, especially in high-risk individuals. In addition, SARS-CoV-2 spike-specific antibodies acquired by prior infection or vaccination act as immune pressure, driving continuous population turnover by selecting for antibody-escaping mutations. Here, we review accumulating knowledge on the potential role of humoral immune responses in COVID-19, primarily focusing on their beneficial and pathogenic properties. Understanding the multifaceted regulatory mechanisms of humoral responses during SARS-CoV-2 infection can help us to develop more effective therapeutics, as well as protective measures against the ongoing pandemic.
© 2022. The Microbiological Society of Korea.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibody-escaping variants; humoral immunity

Mesh:

Substances:

Year:  2022        PMID: 35235178      PMCID: PMC8890013          DOI: 10.1007/s12275-022-2037-8

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   2.902


  97 in total

Review 1.  The intersection of COVID-19 and autoimmunity.

Authors:  Jason S Knight; Roberto Caricchio; Jean-Laurent Casanova; Alexis J Combes; Betty Diamond; Sharon E Fox; David A Hanauer; Judith A James; Yogendra Kanthi; Virginia Ladd; Puja Mehta; Aaron M Ring; Ignacio Sanz; Carlo Selmi; Russell P Tracy; Paul J Utz; Catriona A Wagner; Julia Y Wang; William J McCune
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

2.  Delayed production of neutralizing antibodies correlates with fatal COVID-19.

Authors:  Carolina Lucas; Jon Klein; Maria E Sundaram; Feimei Liu; Patrick Wong; Julio Silva; Tianyang Mao; Ji Eun Oh; Subhasis Mohanty; Jiefang Huang; Maria Tokuyama; Peiwen Lu; Arvind Venkataraman; Annsea Park; Benjamin Israelow; Chantal B F Vogels; M Catherine Muenker; C-Hong Chang; Arnau Casanovas-Massana; Adam J Moore; Joseph Zell; John B Fournier; Anne L Wyllie; Melissa Campbell; Alfred I Lee; Hyung J Chun; Nathan D Grubaugh; Wade L Schulz; Shelli Farhadian; Charles Dela Cruz; Aaron M Ring; Albert C Shaw; Adam V Wisnewski; Inci Yildirim; Albert I Ko; Saad B Omer; Akiko Iwasaki
Journal:  Nat Med       Date:  2021-05-05       Impact factor: 53.440

3.  Diverse functional autoantibodies in patients with COVID-19.

Authors:  Eric Y Wang; Tianyang Mao; Jon Klein; Yile Dai; John D Huck; Jillian R Jaycox; Feimei Liu; Ting Zhou; Benjamin Israelow; Patrick Wong; Andreas Coppi; Carolina Lucas; Julio Silva; Ji Eun Oh; Eric Song; Emily S Perotti; Neil S Zheng; Suzanne Fischer; Melissa Campbell; John B Fournier; Anne L Wyllie; Chantal B F Vogels; Isabel M Ott; Chaney C Kalinich; Mary E Petrone; Anne E Watkins; Charles Dela Cruz; Shelli F Farhadian; Wade L Schulz; Shuangge Ma; Nathan D Grubaugh; Albert I Ko; Akiko Iwasaki; Aaron M Ring
Journal:  Nature       Date:  2021-05-19       Impact factor: 49.962

4.  The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity.

Authors:  Leiqiong Gao; Jing Zhou; Sen Yang; Lisha Wang; Xiangyu Chen; Yang Yang; Ren Li; Zhiwei Pan; Jing Zhao; Zhirong Li; Qizhao Huang; Jianfang Tang; Li Hu; Pinghuang Liu; Guozhong Zhang; Yaokai Chen; Lilin Ye
Journal:  Signal Transduct Target Ther       Date:  2021-03-08

5.  Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Authors:  Yiska Weisblum; Fabian Schmidt; Fengwen Zhang; Justin DaSilva; Daniel Poston; Julio Cc Lorenzi; Frauke Muecksch; Magdalena Rutkowska; Hans-Heinrich Hoffmann; Eleftherios Michailidis; Christian Gaebler; Marianna Agudelo; Alice Cho; Zijun Wang; Anna Gazumyan; Melissa Cipolla; Larry Luchsinger; Christopher D Hillyer; Marina Caskey; Davide F Robbiani; Charles M Rice; Michel C Nussenzweig; Theodora Hatziioannou; Paul D Bieniasz
Journal:  Elife       Date:  2020-10-28       Impact factor: 8.140

6.  Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs.

Authors:  Mark C Howell; Ryan Green; Andrew R McGill; Roukiah M Kahlil; Rinku Dutta; Shyam S Mohapatra; Subhra Mohapatra
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

7.  Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study.

Authors:  Mar Masiá; Marta Fernández-González; Guillermo Telenti; Vanesa Agulló; José A García; Sergio Padilla; Javier García-Abellán; Antonio Galiana; Nieves Gonzalo-Jiménez; Félix Gutiérrez
Journal:  J Autoimmun       Date:  2021-07-20       Impact factor: 7.094

8.  Complement activation in patients with COVID-19: A novel therapeutic target.

Authors:  Massimo Cugno; Pier Luigi Meroni; Roberta Gualtierotti; Samantha Griffini; Elena Grovetti; Adriana Torri; Mauro Panigada; Stefano Aliberti; Francesco Blasi; Francesco Tedesco; Flora Peyvandi
Journal:  J Allergy Clin Immunol       Date:  2020-05-14       Impact factor: 10.793

9.  Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability.

Authors:  Yeon-Sook Kim; Abdimadiyeva Aigerim; Uni Park; Yuri Kim; Hyoree Park; Ji-Young Rhee; Jae-Phil Choi; Wan Beom Park; Sang Won Park; Yeonjae Kim; Dong-Gyun Lim; Ji-Yeob Choi; Yoon Kyung Jeon; Jeong-Sun Yang; Joo-Yeon Lee; Hyoung-Shik Shin; Nam-Hyuk Cho
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

10.  Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.

Authors:  Ana Marcos-Jiménez; Santiago Sánchez-Alonso; Ana Alcaraz-Serna; Laura Esparcia; Celia López-Sanz; Miguel Sampedro-Núñez; Tamara Mateu-Albero; Ildefonso Sánchez-Cerrillo; Pedro Martínez-Fleta; Ligia Gabrie; Luciana Del Campo Guerola; José Miguel Rodríguez-Frade; José M Casasnovas; Hugh T Reyburn; Mar Valés-Gómez; Margarita López-Trascasa; Enrique Martín-Gayo; María José Calzada; Santos Castañeda; Hortensia de la Fuente; Isidoro González-Álvaro; Francisco Sánchez-Madrid; Cecilia Muñoz-Calleja; Arantzazu Alfranca
Journal:  Eur J Immunol       Date:  2021-01-22       Impact factor: 6.688

View more
  1 in total

1.  Two years of COVID-19 pandemic: where are we now?

Authors:  Jinjong Myoung
Journal:  J Microbiol       Date:  2022-03       Impact factor: 3.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.